WHO ICTRP trial
A phase 2, open-label test-retest study to assess the reproducibility of…
EUCTR2008-003835-18-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-003835-18-GB |
|---|---|
| Public title | A phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F uptake by solid tumours using PET imaging following intravenous administration of AH111585 (18F) Injection |
| Scientific title | A phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F uptake by solid tumours using PET imaging following intravenous administration of AH111585 (18F) Injection |
| Primary sponsor | GE Healthcare Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom;Sweden |
| Conditions | Adult subjects with solid primary or metastatic tumours 2 cm or more in diameter. Malignancies may include but are not limited to non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), glioblastoma multiforme (GBM), melanoma… |
| Interventions | Product Name: AH111585 (18F) Injection Product Code: AH111585 Pharmaceutical Form: Solution for injection |
| Registration date | Apr 28, 2009 |
| Target size | 45 |
| Secondary IDs | GE-135-004 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: